SMD Rise PCL (BKK:SMD100-R) Debt-to-Revenue : 0.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SMD100-R SMD Rise PCL BKK:SMD100-R
60 GF Score
Price ฿5.85
GF Value ฿19.07
! 9 Warning Signs
View Full Analysis

What is SMD Rise PCL Debt-to-Revenue?

SMD Rise PCL BKK:SMD100-R 60 Debt-to-Revenue is 0.25 as of Jun. 2026. GuruFocus rates BKK:SMD100-R with a GF Score™ of 60/100 and a GF Value™ of ฿19.07. The stock has 9 warning signs investors should review.

Debt-to-Revenue measures a company's ability to pay off its debt.

SMD Rise PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ฿240 Mil. SMD Rise PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ฿83 Mil. SMD Rise PCL's annualized Revenue for the quarter that ended in Jun. 2026 was ฿1,285 Mil. SMD Rise PCL's annualized Debt-to-Revenue for the quarter that ended in Jun. 2026 was 0.25.

SMD Rise PCL Debt-to-Revenue Historical Data

* Premium members only.

The historical data trend for SMD Rise PCL's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SMD Rise PCL Debt-to-Revenue Chart

SMD Rise PCL Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Revenue
Get a 7-Day Free Trial 0.17 0.03 0.06 0.35 0.36

SMD Rise PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.17 0.32 0.49 0.25

BKK:SMD100-R vs MCK, COR, CAH: Debt-to-Revenue Comparison

For the Medical Distribution subindustry, SMD Rise PCL's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SMD Rise PCL Debt-to-Revenue vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where SMD Rise PCL's Debt-to-Revenue falls into.


BKK:SMD100-R
60GF Score
SMD Rise PCL BKK:SMD100-R
Debt-to-Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SMD Rise PCL Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

SMD Rise PCL's Debt-to-Revenue for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(226.574 + 101.3) / 910.178
=0.36

SMD Rise PCL's annualized Debt-to-Revenue for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(239.583 + 82.991) / 1284.944
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2026) Revenue data.

Frequently Asked Questions Learn more about Debt-to-Revenue →
What does a Debt-to-Revenue of 0.25 mean?
SMD Rise PCL (BKK:SMD100-R) has a Debt-to-Revenue of 0.25 as of Jun. 2026.
Is SMD Rise PCL's Debt-to-Revenue too high?
SMD Rise PCL's current Debt-to-Revenue is 0.25. Overall, SMD Rise PCL has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Debt-to-Revenue compare to MCK and COR?
SMD Rise PCL's Debt-to-Revenue of 0.25 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Revenue for a Medical Distribution company?
A good Debt-to-Revenue depends on the Medical Distribution industry context. However, Debt-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Revenue mean?
A high Debt-to-Revenue can signal that a stock is expensive relative to its fundamentals. SMD Rise PCL's current Debt-to-Revenue is 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Debt-to-Revenue of 0.25. The stock's GF Value™ is ฿19.07, compared to a current price of ฿5.85 — trading 69.3% below its estimated fair value. The current Debt-to-Revenue is 0.25. SMD Rise PCL's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Revenue calculated?
Debt-to-Revenue is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Debt-to-Revenue is 0.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?

Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued. The current stock price of ฿5.85 is trading 69.3% below its estimated GF Value™ of ฿19.07.

Key valuation signals for BKK:SMD100-R:

  • Debt-to-Revenue: 0.25
  • GF Value™: ฿19.07 vs. price of ฿5.85 (69.3% below fair value)
  • GF Score™: 60/100 with 9 warning signs

No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SMD Rise PCL Business Description

Other Exchanges SMD100:Thailand
Address 222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
60GF Score

Get the complete analysis for BKK:SMD100-R

Debt-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.85
Price
฿19.07
GF Value